Health Highlights: Sept. 13, 2008
Saturday, September 13, 2008; 12:00 AM
Here are some of the latest health and medical news developments, compiled by editors ofHealthDay:
Cervical Cancer Vaccine Approved to Combat Two Related Cancers
Gardasil, the vaccine used to guard against cervical cancer, has been approved for similar use against two more gynecological malignancies.
According to theAssociated Press, The U.S. Food and Drug Administration has approved the drug, manufactured by Merck Pharmaceuticals, to guard against cancers that attack the vagina and vulva.
Gardasil fights most of the strains the papillomavirus (HPV) that cause cervical cancer. About 20 million Americans carry HPV, but not all of them develop cancer. About 5,000 women get vulva and vaginal cancer annually, according to the wire service.
CHECK OUT CEO UPCI NEWS LETTER -WIDENING THE VIEW-FOR PREVENTION